Global Single-Use Technologies for the Biologic Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03243263

Publication Date:

March 5, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Single-Use Technologies for the Biologic market size was valued at US$ 4234.6 million in 2023. With growing demand in downstream market, the Single-Use Technologies for the Biologic is forecast to a readjusted size of US$ 8389.3 million by 2030 with a CAGR of 10.3% during review period.
The research report highlights the growth potential of the global Single-Use Technologies for the Biologic market. Single-Use Technologies for the Biologic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Single-Use Technologies for the Biologic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Single-Use Technologies for the Biologic market.
Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies.
Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market.
Key Features:
The report on Single-Use Technologies for the Biologic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Single-Use Technologies for the Biologic market. It may include historical data, market segmentation by Type (e.g., Membrane Adsorber, Bioreactors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Single-Use Technologies for the Biologic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Single-Use Technologies for the Biologic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Single-Use Technologies for the Biologic industry. This include advancements in Single-Use Technologies for the Biologic technology, Single-Use Technologies for the Biologic new entrants, Single-Use Technologies for the Biologic new investment, and other innovations that are shaping the future of Single-Use Technologies for the Biologic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Single-Use Technologies for the Biologic market. It includes factors influencing customer ' purchasing decisions, preferences for Single-Use Technologies for the Biologic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Single-Use Technologies for the Biologic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Single-Use Technologies for the Biologic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Single-Use Technologies for the Biologic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Single-Use Technologies for the Biologic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Single-Use Technologies for the Biologic market.
Market Segmentation:
Single-Use Technologies for the Biologic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Membrane Adsorber
Bioreactors
Disposable Mixing Systems
Tangential Flow Filtration
Tubing and Connectors
Depth Filtration
Buffer Containers
Waste Containers
Segmentation by application
Monoclonal Antibodies
Vaccines
Gene Therapy
Recombinant Proteins
Blood Derivatives
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Applikon Biotechnology
GE Healthcare
Pall
BioPure Technology
Sartorius
Novasep
W. L. Gore and Associates
EMD Millipore
DowDuPont

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Single-Use Technologies for the Biologic Market Size 2019-2030
2.1.2 Single-Use Technologies for the Biologic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Single-Use Technologies for the Biologic Segment by Type
2.2.1 Membrane Adsorber
2.2.2 Bioreactors
2.2.3 Disposable Mixing Systems
2.2.4 Tangential Flow Filtration
2.2.5 Tubing and Connectors
2.2.6 Depth Filtration
2.2.7 Buffer Containers
2.2.8 Waste Containers
2.3 Single-Use Technologies for the Biologic Market Size by Type
2.3.1 Single-Use Technologies for the Biologic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Single-Use Technologies for the Biologic Market Size Market Share by Type (2019-2024)
2.4 Single-Use Technologies for the Biologic Segment by Application
2.4.1 Monoclonal Antibodies
2.4.2 Vaccines
2.4.3 Gene Therapy
2.4.4 Recombinant Proteins
2.4.5 Blood Derivatives
2.5 Single-Use Technologies for the Biologic Market Size by Application
2.5.1 Single-Use Technologies for the Biologic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Single-Use Technologies for the Biologic Market Size Market Share by Application (2019-2024)
3 Single-Use Technologies for the Biologic Market Size by Player
3.1 Single-Use Technologies for the Biologic Market Size Market Share by Players
3.1.1 Global Single-Use Technologies for the Biologic Revenue by Players (2019-2024)
3.1.2 Global Single-Use Technologies for the Biologic Revenue Market Share by Players (2019-2024)
3.2 Global Single-Use Technologies for the Biologic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Single-Use Technologies for the Biologic by Regions
4.1 Single-Use Technologies for the Biologic Market Size by Regions (2019-2024)
4.2 Americas Single-Use Technologies for the Biologic Market Size Growth (2019-2024)
4.3 APAC Single-Use Technologies for the Biologic Market Size Growth (2019-2024)
4.4 Europe Single-Use Technologies for the Biologic Market Size Growth (2019-2024)
4.5 Middle East & Africa Single-Use Technologies for the Biologic Market Size Growth (2019-2024)
5 Americas
5.1 Americas Single-Use Technologies for the Biologic Market Size by Country (2019-2024)
5.2 Americas Single-Use Technologies for the Biologic Market Size by Type (2019-2024)
5.3 Americas Single-Use Technologies for the Biologic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single-Use Technologies for the Biologic Market Size by Region (2019-2024)
6.2 APAC Single-Use Technologies for the Biologic Market Size by Type (2019-2024)
6.3 APAC Single-Use Technologies for the Biologic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Single-Use Technologies for the Biologic by Country (2019-2024)
7.2 Europe Single-Use Technologies for the Biologic Market Size by Type (2019-2024)
7.3 Europe Single-Use Technologies for the Biologic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Single-Use Technologies for the Biologic by Region (2019-2024)
8.2 Middle East & Africa Single-Use Technologies for the Biologic Market Size by Type (2019-2024)
8.3 Middle East & Africa Single-Use Technologies for the Biologic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Single-Use Technologies for the Biologic Market Forecast
10.1 Global Single-Use Technologies for the Biologic Forecast by Regions (2025-2030)
10.1.1 Global Single-Use Technologies for the Biologic Forecast by Regions (2025-2030)
10.1.2 Americas Single-Use Technologies for the Biologic Forecast
10.1.3 APAC Single-Use Technologies for the Biologic Forecast
10.1.4 Europe Single-Use Technologies for the Biologic Forecast
10.1.5 Middle East & Africa Single-Use Technologies for the Biologic Forecast
10.2 Americas Single-Use Technologies for the Biologic Forecast by Country (2025-2030)
10.2.1 United States Single-Use Technologies for the Biologic Market Forecast
10.2.2 Canada Single-Use Technologies for the Biologic Market Forecast
10.2.3 Mexico Single-Use Technologies for the Biologic Market Forecast
10.2.4 Brazil Single-Use Technologies for the Biologic Market Forecast
10.3 APAC Single-Use Technologies for the Biologic Forecast by Region (2025-2030)
10.3.1 China Single-Use Technologies for the Biologic Market Forecast
10.3.2 Japan Single-Use Technologies for the Biologic Market Forecast
10.3.3 Korea Single-Use Technologies for the Biologic Market Forecast
10.3.4 Southeast Asia Single-Use Technologies for the Biologic Market Forecast
10.3.5 India Single-Use Technologies for the Biologic Market Forecast
10.3.6 Australia Single-Use Technologies for the Biologic Market Forecast
10.4 Europe Single-Use Technologies for the Biologic Forecast by Country (2025-2030)
10.4.1 Germany Single-Use Technologies for the Biologic Market Forecast
10.4.2 France Single-Use Technologies for the Biologic Market Forecast
10.4.3 UK Single-Use Technologies for the Biologic Market Forecast
10.4.4 Italy Single-Use Technologies for the Biologic Market Forecast
10.4.5 Russia Single-Use Technologies for the Biologic Market Forecast
10.5 Middle East & Africa Single-Use Technologies for the Biologic Forecast by Region (2025-2030)
10.5.1 Egypt Single-Use Technologies for the Biologic Market Forecast
10.5.2 South Africa Single-Use Technologies for the Biologic Market Forecast
10.5.3 Israel Single-Use Technologies for the Biologic Market Forecast
10.5.4 Turkey Single-Use Technologies for the Biologic Market Forecast
10.5.5 GCC Countries Single-Use Technologies for the Biologic Market Forecast
10.6 Global Single-Use Technologies for the Biologic Forecast by Type (2025-2030)
10.7 Global Single-Use Technologies for the Biologic Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Single-Use Technologies for the Biologic Product Offered
11.1.3 Thermo Fisher Scientific Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Applikon Biotechnology
11.2.1 Applikon Biotechnology Company Information
11.2.2 Applikon Biotechnology Single-Use Technologies for the Biologic Product Offered
11.2.3 Applikon Biotechnology Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Applikon Biotechnology Main Business Overview
11.2.5 Applikon Biotechnology Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Single-Use Technologies for the Biologic Product Offered
11.3.3 GE Healthcare Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Pall
11.4.1 Pall Company Information
11.4.2 Pall Single-Use Technologies for the Biologic Product Offered
11.4.3 Pall Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pall Main Business Overview
11.4.5 Pall Latest Developments
11.5 BioPure Technology
11.5.1 BioPure Technology Company Information
11.5.2 BioPure Technology Single-Use Technologies for the Biologic Product Offered
11.5.3 BioPure Technology Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BioPure Technology Main Business Overview
11.5.5 BioPure Technology Latest Developments
11.6 Sartorius
11.6.1 Sartorius Company Information
11.6.2 Sartorius Single-Use Technologies for the Biologic Product Offered
11.6.3 Sartorius Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sartorius Main Business Overview
11.6.5 Sartorius Latest Developments
11.7 Novasep
11.7.1 Novasep Company Information
11.7.2 Novasep Single-Use Technologies for the Biologic Product Offered
11.7.3 Novasep Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novasep Main Business Overview
11.7.5 Novasep Latest Developments
11.8 W. L. Gore and Associates
11.8.1 W. L. Gore and Associates Company Information
11.8.2 W. L. Gore and Associates Single-Use Technologies for the Biologic Product Offered
11.8.3 W. L. Gore and Associates Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 W. L. Gore and Associates Main Business Overview
11.8.5 W. L. Gore and Associates Latest Developments
11.9 EMD Millipore
11.9.1 EMD Millipore Company Information
11.9.2 EMD Millipore Single-Use Technologies for the Biologic Product Offered
11.9.3 EMD Millipore Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 EMD Millipore Main Business Overview
11.9.5 EMD Millipore Latest Developments
11.10 DowDuPont
11.10.1 DowDuPont Company Information
11.10.2 DowDuPont Single-Use Technologies for the Biologic Product Offered
11.10.3 DowDuPont Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 DowDuPont Main Business Overview
11.10.5 DowDuPont Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂